Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-074673
Filing Date
2021-06-01
Accepted
2021-06-01 08:55:45
Documents
5
Period of Report
2021-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2118054d1_6k.htm 6-K 22584
2 GRAPHIC tm2118054d1_6kimg001.jpg GRAPHIC 321133
3 GRAPHIC tm2118054d1_6kimg002.jpg GRAPHIC 324599
4 GRAPHIC tm2118054d1_6kimg003.jpg GRAPHIC 321357
5 GRAPHIC tm2118054d1_6kimg004.jpg GRAPHIC 83368
  Complete submission text file 0001104659-21-074673.txt   1451811
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 21983238
SIC: 2834 Pharmaceutical Preparations